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Abstract
 
The crystal structures of the 2C/H-2K
 
bm3
 
–dEV8 allogeneic complex at 2.4 Å and H-2K
 
bm3
 
–dEV8
at 2.15 Å, when compared with their syngeneic counterparts, elucidate structural changes that
induce an alloresponse. The Asp77Ser mutation that imbues H-2K
 
bm3
 
–dEV8 with its alloreac-
tive properties is located beneath the peptide and does not directly contact the T cell receptor
(TCR). However, the buried mutation induces local rearrangement of the peptide itself to pre-
serve hydrogen bonding interactions between the peptide and the 
 
 
 
1
 
 77 residue. The COOH
terminus of the peptide main chain is tugged toward the 
 
 
 
1
 
-helix such that its presentation to
the TCR is altered. These changes increase the stability of the allogeneic peptide-major histo-
compatibility complex (pMHC) complex and increase complementarity in the TCR–pMHC
interface, placing greater emphasis on recognition of the pMHC by the TCR 
 
 
 
-chain, evinced
by an increase in shape complementarity, buried surface area, and number of TCR–pMHC
contacting residues. A nearly fourfold increase in the number of 
 
 
 
-chain–pMHC contacts is
accompanied by a concomitant 64% increase in 
 
 
 
-chain–pMHC shape complementarity.
Thus, the allogeneic mutation causes the same peptide to be presented differently, temporally
and spatially, by the allogeneic and syngeneic MHCs.
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Introduction
 
TCR recognition of foreign peptides bound to MHC class
I molecules (pMHCs)
 
* 
 
is the critical first step in CD8
 
 
 
 T
lymphocyte activation. TCR pMHC ligation is followed
by phosphorylation of TCR-related 
 
 
 
-chains and recruit-
ment and activation of ZAP 70. Subsequent activation of
intracellular signaling cascades culminates in release of lytic
granules and the induction of apoptosis in target cells.
Though obligatory recognition of self-MHC molecules by
TCRs is mandated by positive selection during thymic de-
velopment, a significant subset of mature TCRs (1–10%;
reference 1) possess the anomalous potential for alloreactive
interaction and recognition of nonself MHCs.
Class I MHCs, which consist of an MHC heavy chain
and a 
 
 
 
2
 
-microglobulin light chain, are 45-kD antigen-pre-
senting glycoproteins expressed universally in nucleated
cells. Peptides are bound to class I MHCs in an extended
conformation with conserved hydrogen bonding to the
peptide backbone N and C termini (2–4). The peptide side
chains interact with six pockets in the peptide binding
 
groove designated A to F (5). Frequent polymorphisms
therein lead to MHC-specific peptide-binding motifs.
Allelic variation in MHC I genes, arising from germline
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gene conversion (for a review, see reference 6), is the pri-
mary cause of graft rejection and graft-versus-host disease,
the clinical manifestations of alloreactive TCR recognition.
The murine H-2K
 
b
 
 class I gene encodes a classical trans-
plantation antigen within the MHC multigene cluster on
chromosome 17. H-2K
 
bm
 
 proteins are naturally occurring
mutants of the H-2K
 
b
 
 gene and were originally identified
in skin graft experiments by correlating precise amino acid
changes with altered histocompatibility (6). Most H-2K
 
bm
 
molecules are characterized by clusters of amino acid sub-
stitutions, as many as five, occurring in one of either of the
two amino-terminal heavy chain domains, 
 
 
 
1
 
 and 
 
 
 
2
 
 (6).
H-2K
 
bm3
 
 contains two mutations in the 
 
 
 
1
 
 domain. Substi-
tution of serine for aspartate at position 77 determines the
alloreactive phenotype, whereas replacement of alanine for
lysine at position 89 determines the serologic phenotype
(7). H-2K
 
b
 
 is responsible for positive selection of 2C
TCR-bearing cytolytic T lymphocytes in transgenic mice,
whereas H-2K
 
bm3
 
 expression results in negative selection
(8). dEV8 is a self-peptide derived from MLRQ, a compo-
nent of the mitochondrial NADH ubiquinone complex,
that, when bound to H-2K
 
bm3
 
, is an alloligand for the 2C
TCR (9).
Despite starkly contrasting biological properties, surface
plasmon resonance measurements of 2C binding to H-2K
 
b
 
–
dEV8 and H-2K
 
bm3
 
–dEV8 demonstrate that, in an isolated
system, the difference in affinities and binding kinetics of
2C for these pMHCs is remarkably small (10). Although
puzzling, this is not entirely unexpected. Some studies have
reported good correlation between binding kinetics and the
degree of T cell activation, i.e., strong agonists tend to have
longer half lives than do antagonists (for a review, see refer-
ence 11), but an absolute correlation between binding ki-
netics and biological effect has not been experimentally ob-
served (12, 13). However, the question remains as to how
well these measurements reflect the nature of TCR–
pMHC interactions in the presence of accessory molecules,
such as CD8 (14–17), on the surface of the cell, and within
the specialized environment of the immunological synapse
(18). In addition, recent studies suggest that activated T
cells have markedly increased avidity for pMHCs when
compared with their naive counterparts (19).
The TCR is a cell surface glycoprotein consisting of two
disulfide-linked polypeptide chains, 
 
 
 
 and 
 
 
 
, whose bind-
ing orientation relative to the MHC-peptide binding
groove was determined by crystallography to be approxi-
mately diagonal (20, 21, 23–25; for a review, see reference
22). Each chain has four possible complementarity deter-
mining regions (CDRs) with CDRs 1, 2, and 4 being germ-
line encoded and CDR3, the most variable, being formed
during thymic development by D to J and V to D gene re-
arrangements in the 
 
 
 
-chain and V to J gene rearrange-
ments in the 
 
 
 
-chain. Generally, the 
 
 
 
- and 
 
 
 
-chain
CDR3 loops form the majority of direct contacts to the
peptide in TCR–pMHC interactions while the CDRs 1,
2, and, sometimes, 4 primarily contact the 
 
 
 
1
 
- and 
 
 
 
2
 
-heli-
ces that straddle the MHC peptide-binding groove. Thus
far, four independent high resolution TCR crystal struc-
 
tures (
 
 
 
3.2 Å) have been reported with their respective
class I MHCs (20, 21, 26–28). Two independent TCRs
bound to their respective class II MHCs have also been re-
ported (29–31). In crystal structures of the A6 TCR bound
to four distinct peptide–HLA-A2 complexes, no correla-
tion was found between structure and biological activities
that ranged from strong agonism to weak antagonism (32),
raising the question as to how astonishingly dissimilar bio-
logical effects can be manifested by vanishingly small
changes within the TCR–pMHC interface. Likewise, the
structure of the 2C/H-2K
 
b
 
–SIYR depicted very similar
overall binding between a weak agonist and a superagonist,
with functionally significant changes restricted to interac-
tion of the P4 and P6 residues of the peptide with a “hot
spot” around the TCR CDR3
 
 
 
 and CDR3
 
 
 
 (18). The
BM3.3 TCR in complex with the H-2K
 
b
 
–pBM1 MHC-
peptide ligand revealed that, in the allogeneic interaction,
the diagonal orientation of the TCR with respect to the
antigen binding interface is preserved (28). However, com-
parison with the specific equivalent syngeneic complex was
not possible as its structure has not yet been determined.
This study enables, for the first time, a comparative analysis
of the structures of a single TCR bound to both self and
nonself MHC in the presence of the same bound peptide.
 
Materials and Methods
 
Affinity Measurements of Peptides Bound to H-2K
 
b
 
 and H-2K
 
bm3
 
.
 
Affinity measurements for binding of peptides to soluble H-2K
 
b
 
and H-2K
 
bm3
 
 molecules were performed as described previously
(33, 34). In brief, VSV8 peptide was labeled with 
 
125
 
I using the
iodogen method. The 
 
125
 
I-VSV8 peptide was purified using a
Sep-Pak column (Waters). The competition assays were per-
formed at 23
 
 
 
C and 37
 
 
 
C as described (33) with few modifica-
tions. The binding studies were performed in 1% FCS and the
free peptide was removed by gel filtration using Sephadex col-
umns (NAP-5; Amersham Pharmacia Biotech). The dissociation
constants for unlabeled peptides were determined from the molar
concentrations of unlabeled peptides that gave 50% inhibition of
 
125
 
I-VSV8 binding to H-2K
 
b
 
 or H-2K
 
bm3
 
 molecules.
 
Protein Expression, Purification, and Crystallization.
 
Protein was
overexpressed and purified as described previously (10). 2C and
H-2K
 
bm3
 
–dEV8 were mixed in 1:1 molar ratio (
 
 
 
0.2 mM), and
crystals of the 2C/H-2K
 
bm3
 
–dEV8 complex were obtained by sit-
ting drop vapor diffusion at 4
 
 
 
C with a 1:1 mixture of protein
and mother liquor containing 0.1 M Tris-acetate pH 6.9, 12.5%
PEG4000, and 20% glycerol.
 
Data Collection and Refinement Methods.
 
Crystals were cryo-
cooled to 
 
 
 
170
 
 
 
C in a nitrogen stream. X-ray diffraction data
were collected at beamline 9–1 of the Stanford Synchrotron Radi-
ation Laboratory (SSRL) on a MAR345 image plate using a
monochromatic wavelength of 1.0 Å. The 2C/H-2K
 
bm3
 
–dEV8
crystals are isomorphous with the previously reported 2C/H-2K
 
b
 
–
SIYR crystals (18) in the orthorhombic space group P2
 
1
 
2
 
1
 
2. The
structure was determined by direct refinement using the coordi-
nates of the 2C/H-2K
 
b
 
–SIYR complex as a model (PDB code
1G6R). The structure was initially refined by rigid body methods
using the seven independent TCR and MHC domains against the
maximum likelihood target (35). Iterative cycles of torsion angle
dynamics using a maximum likelihood target function and slow- 
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cooling temperature protocols with the program CNS (35) were
combined with manual model adjustment. Bulk solvent correction
with a flat model and anisotropic correction were used throughout
the refinement. The model was rebuilt in density modified, com-
posite omit, and 
 
 
 
A
 
-weighted 3Fo-2Fc and Fo-Fc maps (36) using
the program O (37). A final round of refinement was conducted in
REFMAC5 using TLS parameters (38), yielding an R
 
cryst
 
 of 28.2%
and an R
 
free
 
 of 31.1%. Progress of the refinement was assessed by
continuously monitoring continuously R
 
free
 
 for cross validation
(39), and avoiding divergence between R
 
cryst
 
 and R
 
free
 
. One of the
two independent copies of the TCR in the asymmetric unit is
highly disordered, as found in other 2C/pMHC crystals (18, 26).
The high Wilson B factor derived from the diffraction intensities
correlates with the overall average B value of the model. Analysis
of the final model with PROCHECK (40) shows no outliers and
83.7% and 65.6% of residues in the most favored regions of the
Ramachandran plot in the first and second complex, respectively.
Shape complementarity (SC) coefficients, excluding water molecules
 
(41), were calculated using SC as implemented in CCP4 (42) with
a 1.7 Å probe. Buried surface area was calculated using the pro-
gram MS with a 1.7 Å probe (43). Hydrogen bonds and TCR-
pMHC contacts were identified using the programs HBPLUS (44)
and CONTACSYM (45).
Crystals of H-2K
 
b
 
–dEV8 and H-2K
 
bm3
 
–dEV8 were grown as
described previously (46) and cryocooled after soaking in mother
liquor supplemented with 20% glycerol. Diffraction data for H-2K
 
b
 
–
dEV8 and H-2K
 
bm3
 
–dEV8 were collected on the MAR345 image
plate detector at beamline 9–1 at SSRL and an in-house 30 cm
MAR image plate detector, respectively. All data (see Table I)
were integrated and reduced with DENZO and SCALEPACK
(47). The H-2K
 
b
 
–dEV8 structure was determined by molecular
replacement (AMORE [48]) using H-2K
 
b
 
–SEV9 (PDB code
1VAB) as an overall search model. After rigid-body refinement of
individual domains the H-2K
 
b
 
 molecules were refined using slow-
cool protocols as implemented in X-PLOR version 3.85 (49). Sol-
vent mask correction was applied throughout the refinement, and
 
Table I.
 
Summary of Crystallographic Data and Refinement
 
Data collection 2C/K
 
bm3
 
/dEV8 K
 
b
 
/dEV8 K
 
bm3
 
/dEV8
Wavelength (Å) 1.00 1.00 1.54
Resolution (Å) 2.4 (2.44–2.40)
 
a
 
1.65 (1.71–1.65) 2.15 (2.23–2.15)
No. observations 351,477 339,981 274,981
No. unique reflections 95,548 56,955 29,655
Completeness (%) 99.5 (99.3) 86.5 (89.2) 98.6 (99.2)
R
 
merge
b
 
0.052 (0.453) 0.058 (0.682) 0.087 (0.472)
I/
 
 
 
22.4 (2.4) 28.6 (3.0) 24.4 (4.0)
Wilson B (Å
 
2
 
) 55.6 18.0 28.3
Refinement statistics
Resolution (Å) 50.0–2.4 10.0–1.75 10–2.15
No. reflections 90,694 47,278 27,550
No. in test set 4,781 1,878 1,738
R
 
cryst
c
 
 (%) 28.2 20.6 20.6
R
 
free
d
 
 (%) 31.1 25.1 25.8
Rmsd bonds (Å) 0.008 0.010 0.012
Rmsd angles (
 
 
 
) 1.64 1.62 1.72
No. waters 726 401 277
Average B (Å
 
2
 
)
Protein after TLS 50 (27, 73)
 
e
 
NA NA
Protein before TLS 65 (42, 88)
 
e
 
23 29
Waters 58 [84]
 
f
 
44 50
Ramachandran plot (%)
Most favored 74.7 (83.7, 65.6)
 
e
 
91.8 91.2
Additionally allowed 22.9 (15.5, 30.3)
 
e
 
7.3 8.5
Generously allowed 2.5 (0.8 4.1)
 
e
 
0.9 0.3
Disallowed 0.0 0.0 0.0
NA, not applicable.
 
a
 
Numbers in parentheses refer to the highest resolution shell.
 
b
 
R
 
merge
 
 
 
 
 
 [
 
 
 
h
 
 
 
 
 
i|I
 
i
 
(h) 
 
    I(h)   | /  h  i Ii(h)]   100, where   I(h)   is the mean of the I(h) observation of reflection h.
cRcryst    hkl |Fo   Fc|/ hkl |Fo|.
dRfree was calculated as for Rcryst, but on 4% of the data excluded from the refinement.
e(complex1, complex2).
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Rcryst and Rfree values were used to monitor the refinement
progress. The model was then subjected to several rounds of alter-
nating slowcool/positional refinement and manual model adjust-
ing/rebuilding using the program O (37). The structure was re-
fined to 1.7 Å with an Rcryst and Rfree of 20.6% and 25.1%,
respectively (see Table I). The structure of H-2Kbm3–dEV8 was
determined by molecular replacement using H-2Kb–dEV8 as a
search model and was refined to 2.1 Å with a protocol similar to
that used for the refinement of H-2Kb–dEV8 to Rcryst and Rfree
values of 20.6 and 25.8%, respectively (see Table I). Fig. 1 was cre-
ated with Insight II (Molecular Simulations, Inc.). Figs. 2 and 3
were created with BOBSCRIPT (50) and RASTER3D (51). Fig.
4 was created with GRASP (52).
Results
Structure Determination. Alloreactivity is predicated on
recognition of nonself MHCs by T cells. The question as
to how single-site polymorphism in an MHC class I mole-
cule can transform a syngeneic ligand into an allogeneic
one was investigated by determining the crystal structure of
the H-2Kbm3–dEV8 alloligand in both its free and TCR-
bound forms. The 2.4 Å resolution of this allogeneic TCR–
pMHC complex has been significantly extended over that
of the original syngeneic 2C/H-2Kb–dEV8 complex at 3.2 Å.
The 2C/H-2Kbm3–dEV8 structure was determined by di-
rectly refining the coordinates of the 2C/H-2Kb–SIYR com-
plex (PDB code 1G6R), with peptide atoms removed and
mutated residues truncated to alanine, against the diffraction
data. The 2C/H-2Kb–SIYR crystal structure was used as a
model in direct refinement because the crystals were more iso-
morphous with those of 2C/H-2Kbm3–dEV8 and yielded
lower initial R values after rigid body refinement than did
the molecular replacement solution derived after using any
one of a number of different initial models. Final Rcryst and
Rfree values were 28.2 and 31.1%, respectively, reflecting
the extent of disorder in the second TCR–pMHC com-
plex in the asymmetric unit, as noted in previous 2C TCR
structure determinations (18, 26). However, the first com-
plex was well-ordered and refined with relatively low B val-
ues (Table I). Both copies of the TCR–pMHC complex in
the asymmetric unit include residues 1–213 of the TCR
 -chain, residues 1–247 of the  -chain, residues 1–99 of
the MHC  2-microglobulin light chain, residues 1–274 of
the MHC heavy chain, and residues 1–8 of the peptide.
The structure includes 726 water molecules, 16 carbohy-
drate residues, 3 glycerol molecules, and 1 acetate ion.
The resolution of the unliganded H-2Kb–dEV8 was also
extended to 1.75 Å from the original 2.3 Å (26). The struc-
ture was determined by molecular replacement using wild-
type H-2Kb coordinates (1VAB; reference 2) as a search
model and refined to 1.75 Å with Rcryst and Rfree values of
20.6 and 25.1%, respectively. The H-2Kb–dEV8 structure
includes 401 water molecules, 4 carbohydrate residues, and
2 phosphate ions. The H-2Kbm3–dEV8 structure was deter-
mined by molecular replacement using this new H-2Kb–
dEV8 structure as a model and refined to 2.15 Å with Rcryst
and Rfree values of 20.6 and 25.8%, respectively. The struc-
ture includes 278 water molecules, 4 carbohydrate residues,
and 1 phosphate ion.
Comparison of the Unliganded Syngeneic and Allogeneic
pMHCs. The peptide-binding  1 2 domains of H-2Kb–
dEV8 and H-2Kbm3–dEV8 superimpose with an r.m.s. de-
viation of 0.48 Å for all main-chain atoms. The peptide is
bound by both MHCs in an extended conformation (Fig. 1
Figure 1. Superposition of dEV8 peptides from the free and TCR-
bound forms of pMHCs. (A) Comparison of the unbound H-2Kb–dEV8
(magenta) and unbound H-2Kbm3–dEV8 (green) complexes. (B) Compar-
ison of the TCR-bound H-2Kb–dEV8 (PDB code 2CKB) (cyan) and
TCR-bound H-2Kbm3–dEV8 (orange). (C) Comparison of the unbound
H-2Kb–dEV8 (magenta) and TCR-bound H-2Kb–dEV8 (cyan) (PDB
code 2CKB). (D) Comparison of the unbound H-2Kbm3–dEV8 (green)
and TCR-bound H-2Kbm3–dEV8 (orange).1179 Luz et al.
A) with the side chains of anchor residues Phe-P5 and
Val-P8 binding in the C and F pockets, respectively. In
H-2Kb–dEV8, the side-chain torsion angles at  1 and  2 of
Tyr-P6 are –71  and –10 , respectively, while in H-2Kbm3–
dEV8, a substantial rotation to angles of –175  at  1 and
–90  at  2 results in displacement of the hydroxyl oxygen
by 9.4 Å (Figs. 1 A, 2 A, and 2 B). Of interest, a previous
modeling study predicted a difference in the orientation of
this side chain, although in those studies the P6 side-chain
rotamers in the syngeneic and allogeneic complexes were
reversed (53) relative to those observed in the actual crystal
structures. The torsion angle at  1 of Ser-P7 in H-2Kb–
dEV8 is –75 , compared with 57  in H-2Kbm3–dEV8 (Figs.
1 A, 2 A, and 2 B). The root mean square (r.m.s.) deviation
for the peptide main-chain atoms is only 0.47 Å, but the
largest deviation occurs in the four COOH-terminal resi-
dues (r.m.s. deviation 0.60 Å) and represents a shift in the
peptide backbone toward the  1-helix of H-2Kbm3. Al-
though the side chain of H-2Kbm3 Ser77 is shorter than that
of H-2Kb Asp77, the hydrogen bond from the MHC side-
chain hydroxyl to the main-chain nitrogen of P8 is pre-
served (Fig. 2 B) by a displacement of P7 and P8 backbone
nitrogens by 0.9 Å and 0.5 Å, respectively, toward the  1-
helix, which bears the Asp77Ser mutation.
Other structural rearrangements occur in the vicinity of
Ser77 in H-2Kbm3. A different rotamer of Ser73 ( 1   –72 )
is found in the H-2Kb–dEV8 compared with H-2Kbm3–
dEV8 ( 1   –179 ; Fig. 2, A and B). In H-2Kb–dEV8, the
hydroxyl of Ser73 is rotated away from the Asp77 side
chain, forming a hydrogen bond with the carbonyl oxygen
of P5 (Fig. 2 A). In H-2Kbm3–dEV8, Ser73 O  hydrogen
bonds to the amide nitrogen of Ser-P7 beneath which two
waters (W2 and W7) are buried (Fig. 2 B), partially filling
space vacated by the Asp77Ser substitution. In H-2Kb–
dEV8, one water (W2) molecule is buried beneath Ser-P7
(Fig. 2 A). A water molecule (W1) coordinated by Asp77
and Thr80 side chains and the Val-P8 terminal carboxylate
in most H-2Kb structures (PDB codes 1FZJ, 1FZK, 1FZO,
1KGB, 1VAC, 1VAB, 1G7Q, 1G7P), is absent in the alloge-
neic mutant (Fig. 2 B). In this H-2Kb–dEV8 structure, W1 is
slightly beyond hydrogen bonding distance from the Asp77
carboxylate, but close enough for a polar interaction (3.8
Å; Fig. 2 A).
Comparison of Allogeneic and Syngeneic TCR–pMHC Com-
plexes. The 2C/H-2Kbm3–dEV8 complex (Fig. 3) has the
same gross structural features as previously described for
other class I–restricted TCR–pMHC structures with the
TCR binding the pMHC in a diagonal orientation and the
variable domains contacting the pMHC via their CDR
loops (21, 26–28). TCR V -pMHC contacts are clustered
in the neighborhood of the NH2-terminal half of the
bound peptide, while the TCR V -pMHC contacts are
focused on the COOH-terminal region of the peptide. 2C
binds H-2Kb–dEV8 and H-2Kbm3–dEV8 in a remarkably
similar fashion (Fig. 3) with an r.m.s. deviation of 1.07 Å
for all main-chain atoms of the V  and V  variable do-
mains. The pMHC-contacting CDR loops for both V 
and V  superimpose with an overall r.m.s. deviation for all
main-chain atoms of 1.08 Å with the majority of contacts
between the 2C and H-2Kb–dEV8 being conserved in the
Figure 2. Effect of the alloreactive muta-
tion on peptide-MHC and peptide-MHC–
TCR interactions. Hydrogen bonding net-
works to the peptide proximal to Asp77Ser
mutation are reorganized. Hydrogen bond-
ing around the Asp77Ser mutation is shown
between the peptide and MHC (A and B)
and between peptide, MHC, and TCR (C
and D). (A) H-2Kb–dEV8, (B) H-2Kbm3–
dEV8, (C) 2C/H-2Kb–dEV8 (PDB code
2CKB), and (D) 2C/H-2Kbm3–dEV8. Pep-
tide in yellow, MHC in cyan, TCR in green,
water molecules in red.1180 Crystal Structure of an Alloreactive TCR–pMHC Complex
allogeneic complex. The greatest individual r.m.s. devia-
tions are found in CDR3  and CDR3  (1.11 and 1.18 Å,
respectively; Table II), CDRs that were previously identi-
fied as forming a functional hot spot for 2C TCR recogni-
tion (18). The CDR3  loop C  atoms at Ala101 and
Ala103 are displaced by 1.83 Å and 1.15 Å, respectively, in
the allogeneic complex. In both complexes, the dEV8 is
bound in a similar orientation (compare Fig. 1 A versus 1
B, Fig. 3) with an r.m.s. deviation for all atoms of 0.90 Å
and for main-chain atoms of 0.66 Å. The three COOH-
terminal residues of the peptide, proximal to the Asp77Ser
mutation have an increased r.m.s deviation of 0.82 Å for
backbone atoms.
Bound Water Molecules. 15 ordered water molecules
surround the CDR1  loop, four of which mediate TCR–
pMHC contact (Fig. 3). One conserved water molecule
(W14; Fig. 3) bridges the hydroxyl of Tyr31 of the TCR
 -chain and the amide nitrogen of Lys-P4. A second wa-
ter (W10) forms hydrogen bonds with both Glu166 of the
MHC heavy-chain and CDR1  Thr29 O . Waters bound
to the CDR1  main chain at the amide nitrogen (W12)
and carbonyl oxygen of Thr29 (W13) mediate contact
with the carboxylate of Glu-P1 and O  of Thr163, re-
spectively (Fig. 3). An acetate ion was placed into unas-
signed Fo-Fc density in the solvent channel between the
CDR1  loop and the peptide backbone of residues P2 and
P3. The higher resolution of the allogeneic complex also
reveals numerous water molecules positioned around the
CDR2  loop, one of which mediates contact between the
TCR and the pMHC (W11), bridging the carboxylate of
MHC Glu166 and the amide nitrogen of Gly52 in the
TCR  -chain.
A water molecule (W15), not previously observed, me-
diates contact between the N  of Lys-P4 and the hydroxyl
of Ser93. Unambiguous density places the amide side-chain
oxygen of the TCR  -chain Gln1 within hydrogen bond-
ing distance of the backbone nitrogens of both Gly99 and
Phe100 of the CDR3 . Contacts between the CDR3 
loop and the pMHC are similar with the side chain of
Lys-P4 protruding out from the MHC binding groove and
into a pocket bounded by CDR3  and CDR3 .
For CDR1 , a water (W16) is within hydrogen bonding
distance of the carbonyl oxygen of Asn28, the side-chain
hydroxyl of Tyr-P6, and the carbonyl oxygen of H-2Kbm3
Lys146. As opposed to the wild-type structure, the hydro-
gen bonding partner of the Asn30 amide side-chain nitro-
gen is the backbone carbonyl oxygen of Ser-P7, not its
side-chain O .
The resolution (2.5 Å) of the BM3.3/H-2Kb–pBM1
structure also allowed delineation of numerous waters in
the TCR–pMHC interface (28). The similar resolution of
2C/H-2Kbm3–dEV8 thus allows for comparison of water-
mediated contacts in the two structures. 12 waters mediate
contact between the TCR and the MHC in BM3.3/H-2Kb–
pBM1, while 6 waters mediate contact in 2C/H-2Kbm3–
dEV8; none are equivalent in both structures. Four waters
in the peptide-binding groove are conserved between the
allogeneic BM3.3/H-2Kb–pBM1 and the 2C/H-2Kbm3–
dEV8 structures, but none mediates contact with the TCR
in both structures.
TCR–pMHC Interface and Complementarity. Although
the Asp77Ser mutation in the H-2Kb heavy chain might
have abolished the hydrogen bond between the side chain
of residue 77 and the amide nitrogen of Leu-P8 (26), the
hydrogen bond between these residues is preserved (com-
pare Fig. 2, C and D). Movement of the peptide main
chain toward the  1-helix maintains the Ser77 hydrogen
bond with Leu-P8 and also brings O  of Ser-P7 within hy-
Figure 3. Comparison of syngeneic and allogeneic 2C
TCR–pMHC complexes. The syngeneic 2C/H-2Kb–
dEV8 complex is in gray; the allogeneic 2C/H-2Kbm3–
dEV8 complex is colored, V  CDRs (1–4) in cyan, V 
CDRs (1–4) in yellow, H-2Kbm3   1 and  2 helices in
green, dEV8 (P1-P8) in red, and waters directly mediating
TCR–pMHC contact in purple.
Table II. r.m.s. Deviations between the 2C TCR CDR Loops of 
Allogeneic H-2Kbm3 and Syngeneic H-2Kb Complexes
CDR r.m.s.d. (Å)
CDR1  (A:24–31) 0.97
CDR2  (A:48–55) 0.51
CDR3  (A:93–104) 1.11
CDR1  (B:26–31) 0.74
CDR2  (A:48–55) 0.82
CDR3  (B:95–107) 1.181181 Luz et al.
drogen bonding distance of heavy chain Ser73 O  (Fig. 2
D). The plane of the Trp147 indole ring is now rotated
such that its indole nitrogen, along with the N 2 of Asn30
in the CDR1  loop, can make a hydrogen bond to the
backbone carbonyl oxygen of Ser-P7. In the lower resolu-
tion wild-type complex, N 2 of CDR1  Asn30 is more
than 5 Å distant from the carbonyl oxygen of Ser-P7 (Fig.
2 C). It was postulated that N 2 of Asn30 may hydrogen
bond to the O  of Ser-P7 in the wild-type structure (26),
but, at this resolution, the geometry and distance are not
ideal for such a bond (Fig. 2 C). The novel hydrogen bond
between N 2 of CDR1  Asn30 and the peptide in the 2C/
H-2Kbm3–dEV8 complex is also absent in the 2C/H-2Kb–
SIYR superagonist complex. Thus, local changes to the
peptide and MHC in the vicinity of the Asp77Ser mutation
actually promote a more intimate union between the TCR
CDR1  loop and the pMHC.
In the 2C/H-2Kb–dEV8 structure, a total of 981 Å2 of
pMHC surface area is buried by the TCR with 232 Å2
(23.6%) contributed by the peptide. In the 2C/H-2Kbm3–
dEV8 structure, 2C buries 965 Å2 of pMHC surface area,
approximately equal to that buried in the 2C/H-2Kb–
SIYR complex, with 256 Å2 (26.5%) contributed by the
peptide. Thus, even though the overall pMHC buried sur-
face area is smaller in the mutant complex, the contribution
of the peptide is slightly greater. Despite a smaller pMHC
buried surface in the mutant complex, the shape comple-
mentarity (Sc) coefficient (41) is significantly higher for the
mutant (0.62) than for the wild-type complex (0.41; see
Fig. 5 A) and, surprisingly, even greater than that of the
2C/H-2Kb–SIYR superagonist complex (0.49).
Graphical mapping of the TCR–pMHC complementar-
ity onto the individual surfaces of the TCR and pMHC
(Fig. 4) demonstrates that the increase in shape comple-
mentarity is most pronounced for the CDR loops of the
 -chain and pMHC residues proximal to, and including, the
COOH-terminal residues of the peptide. Sc coefficients
calculated independently for the TCR  - and  -chains
confirm this observation; 2C bound to H-2Kb has Sc coef-
ficients of 0.48 and 0.43 for the   and   chains, respec-
tively (Fig. 5 A). When bound to H-2Kbm3, the 2C  - and
 -chains have Sc coefficients of 0.59 and 0.72, respectively.
The summation of protein–protein contacts also indicates a
shift in emphasis toward recognition of the pMHC by the
2C  -chain. Of the 121 contacts tabulated between 2C and
H-2Kbm3–dEV8, 66 are established by the  -chain and 55
by the   chain (Fig. 5 B). In contrast, the 2C/H-2Kb–
dEV8 interaction is dominated by contacts with the
 -chain, 71 contact versus only 18 for the  -chain (26).
The vast majority of the additional  -chain contacts in the
mutant complex arise from van der Waals interactions;
therefore, the changes at the interface are less well reflected
Figure 4. A comparison of shape com-
plementarity at the TCR–pMHC interface
between the allogeneic (2C/H-2Kbm3–
dEV8) and syngeneic complexes (2C/H-2Kb–
dEV8). Shape complementarity is markedly
increased at the TCR  -chain interface in
the allogeneic complex. Shape complemen-
tarity at the TCR–pMHC interfaces was
calculated using SC as implemented in
CCP4 (CCP4, 1994) and mapped onto the
corresponding surfaces in GRASP (refer-
ence 52). (A) 2C/H-2Kb–dEV8 (PDB code
2CKB). 2C at top and H-2Kb–dEV8 at
bottom. (B) 2C/H-2Kbm3–dEV8. 2C at top
and H-2Kbm3–dEV8 at bottom. The inten-
sity of the cyan surface correlates with the
magnitude of the Sc coefficient on the pro-
jected surface. Shape complementarity in-
creases in 2C/H-2Kbm3–dEV8 at the surface
projected by  -chain (area within the en-
closed ovals).1182 Crystal Structure of an Alloreactive TCR–pMHC Complex
by changes in the buried surface area calculations using a 1.7 Å
probe. However, when the pMHC surface areas buried
by the two chains of the TCR are calculated independently
for the mutant and wild-type complexes, the surface area
buried by the  -chain is slightly greater in the allogeneic
complex, 462 Å2 versus 454 Å2, even though the total
pMHC surface area buried in the syngeneic complex is
greater. A concomitant slight decrease in pMHC surface
area buried by the  -chain is also found in the mutant
complex (466 Å2) versus the wild-type (486 Å2; Fig. 5 C).
Of interest, the Sc coefficient calculated for the BM3.3/
H-2Kb–pBM1 structure (PDB code 1FO0) is 0.60, and its
total buried pMHC surface area was determined to be sig-
nificantly smaller (1478 Å2; reference 28) than that for 2C/
H-2Kb–dEV8 (2039 Å2).
Comparison of Liganded and Unliganded H-2Kbm3–dEV8.
As in the syngeneic structures, the side-chain of Tyr-P6 in
H-2Kbm3–dEV8 must shift to accommodate the CDR1 
loop of 2C. However, in contrast to the equivalent wild-
type structures (Fig. 1 C), the  1 and  2 angles of P6
change little between the bound and unbound H-2Kbm3–
dEV8 (Fig. 1 D), and the bulky aromatic ring of the side
chain is repositioned only by a local lateral movement of
the peptide main chain toward the  2-helix, which is also
seen in the syngeneic complex. The C  carbon of P6 is
displaced by 1.5 Å toward the  2-helix. However, relative
to the syngeneic complex, the P7 backbone nitrogen is
pulled closer to the  1-helix in order to preserve the hy-
drogen bond from MHC residue 77 to the peptide in the
alloreactive complex. Despite significant local changes in
the disposition of the peptide, buried waters hydrogen
bonded to the carbonyl oxygen of Phe-P5 (W6) and the
amide nitrogen of Tyr-P6 (W5) are conserved (Fig. 2, B
and D) with coordinates being shifted the same distance
and in the same direction as the peptide main chain. The
side-chain conformation of Glu152 in the  2-helix must be
reorganized to avoid clashing with the main-chain shift in
the peptide.
The Ser-P7  1 angle is rotated 172  in the unliganded
H-2Kbm3–dEV8 to  48  in the liganded molecule (Fig. 1, B
versus D). In the allogeneic pMHC, movement of the pep-
tide main chain toward the  2-helix upon TCR ligation
increases the distance between the hydroxyl of Ser73 and
the amide nitrogen of Ser-P7 with which it forms a hydro-
gen bond (Fig. 2 B). This increase in the hydrogen bonding
distance may weaken the bond sufficiently such that O  of
Ser73 preferentially hydrogen bonds with O  of Ser-P7
(Fig. 2 D). However, what causes the dissolution of the hy-
drogen bond between O  of Ser-P7 and the terminal car-
boxyl of Val-P8 (compare Fig. 2, B and D) in the liganded
H-2Kbm3–dEV8 is not clear.
Stability of H-2Kb and H-2Kbm3 Complexes. In competi-
tive binding assays, dEV8 was shown to bind H-2Kbm3
with greater affinity than H-2Kb at both 23 C (1.3 versus
11.1 nM, respectively) and 37 C (30.4 versus 90.1 nM, re-
spectively; Table III). As a control, binding to the peptide
OVA8 was measured for both H-2Kb and H-2Kbm3. The
affinity of H-2Kbm3 for OVA8 was less than that for
H-2Kb at both 23 C (13.3 versus 4.5 nM, respectively)
and 37 C (160.2 versus 82.2 nM, respectively). This would
indicate that the increase in affinity of H-2Kbm3 for dEV8
Figure 5. Bar graphs depicting changes in contacts, shape comple-
mentarity, and buried surface area in 2C/H-2Kbm3–dEV8 relative to
2C/H-2Kb–dEV8. Recognition by the  -chain is emphasized in the allo-
geneic (orange bar) vs. syngeneic (blue bar) complex. Bars at left compare
pMHC interactions with the entire TCR ( ,  ), middle bars compare
pMHC interactions with the  -chain, and bars at right compare pMHC
interactions with the  -chain. (A) Number of overall contacts between
TCR and pMHC and number of pMHC contacts for individual chains.
(B) Sc coefficients for 2C bound to H-2Kb–dEV8 and H-2Kbm3–dEV8
and Sc coefficients for individual chains. (C) Buried pMHC surface area
for 2C bound to H-2Kb–dEV8 and H-2Kbm3–dEV8, and pMHC surface
area buried by individual   and   chains.1183 Luz et al.
is likely not a reflection of an increase in affinity for pep-
tides in general.
Discussion
The difference in affinities of 2C for H-2Kb–dEV8 and
H-2Kbm3–dEV8 are small and likely close to the margin of
error for the system (surface plasmon resonance) in which
binding was quantified. Nevertheless, the dissociation rate
of 2C for H-2Kbm3–dEV8 (4.8   0.4 s 1   10 2) is mea-
surably decreased relative to that for H-2Kb–dEV8 (18.5  
2.0 s 1   10 2; reference 10); a longer half-life for this in-
teraction would be in agreement with a generally estab-
lished relationship between off-rates and degree of agonism
(11). Although the mutation that confers alloreactivity to
H-2Kbm3 does not directly contact the TCR, it does result
in repositioning of the peptide such that a novel hydrogen
bond is formed between the TCR and the peptide and the
number of van der Waals contacts between the TCR and
the pMHC in the neighborhood of the peptide is signifi-
cantly increased. This hydrogen bond is formed between
Asn30 of CDR1  and Ser-P7, which is positioned above
the Asp77Ser mutation (Fig. 2 D). Loss of a single hydro-
gen bond in a protein–protein interaction can reduce the
affinity of the interaction by as much as three orders of
magnitude (54). The novel hydrogen bonding network,
additional van der Waals contacts in the 2C/H-2Kbm3–
dEV8 complex, and altered peptide presentation convert
this interaction into an allogeneic one that results in nega-
tive selection. Another possible explanation for the allore-
active nature of H-2Kbm3–dEV8 is an increase in affinity of
the allogeneic MHC for the dEV8 peptide relative to the
syngeneic molecule (Table III). In a related study, the cell-
surface density of the H-2Ld alloantigen appeared to dic-
tate positive or negative selection (55). An  16-fold de-
crease in the H-2Ld cell-surface density resulted in positive
rather than negative selection of 2C-bearing cytotoxic T
lymphocytes. However, the differences in H-2Ld cell-sur-
face density between negatively and positively selecting
cells in this study would appear to be greater than could be
explained by a threefold increase in affinity, such as that
seen for H-2Kbm3–dEV8 at 37 C.
One model proposed to explain the frequency of allore-
active T cells is dependent on presentation of a unique set
of self-peptides by allogeneic MHC molecules (56). The
H-2Kbm3 system would appear to be in disagreement with
this peptide-dependent hypothesis because presentation of
the same peptide results in both positive and negative se-
lection depending on the allelic variant of the MHC by
which it is presented. However, the mutations in the
MHC alter the disposition of the peptide such that the
TCR may be “seeing” an altered view of the peptide
when presented by the mutant MHC. Thus, although the
peptide is chemically identical in the syngeneic and alloge-
neic pMHC molecules, from the perspective of the TCR,
it may be unique when considered in the context of the
syngeneic and allogeneic pMHCs. The structural data pre-
sented here, therefore, can be reconciled with this model.
A second hypothesis, based on allogeneic TCRs directly
discriminating between the polymorphic changes in the
 -helices of the allogeneic MHC (57), does not fit in this
case, as the definitive alloreactive mutation in H-2Kbm3 is
buried in the peptide-binding groove and does not directly
contact the TCR.
Numerous reports have identified water molecules as
compensatory elements in protein–protein interactions, oc-
cupying positions vacated by mutated side chains. In keep-
ing with this observation, an additional water molecule
is found in the cavity partially vacated by the aspartate to
serine mutation at position 77 in the heavy chain in H-2Kbm3–
dEV8. In the H-2Kbm1–VSV8 complex, a water molecule
reestablishes hydrogen bonding to the peptide where it has
been abolished by the Glu152Ala mutation (58). In the
complexes of the HyHEL-5 (54) and D1.3 (59) antibodies
bound to lysozyme, buried water molecules occupy cavities
formed by Arg68Lys and Asp18Ala mutations, respectively.
In the Phe78Ser mutant of Rac (60), a member of the
RHO GTPase family, and in the Leu41Ala mutant of
ROP (61), an RNA-binding protein involved in plasmid
replication, waters occupy analogous positions. In H-2Kb–
dEV8, the water molecule bound to the carbonyl oxygen
of Tyr6 in the peptide is coordinated by O 2 of heavy
chain Asp77. In H-2Kbm3–dEV8, the conserved water
bound to the Tyr6 carbonyl is coordinated by a second wa-
ter which occupies the cavity expanded by the Asp77Ser
mutation. The novel cavity-filling water in turn bridges the
hydroxyl oxygens of MHC heavy chain Ser73 and Ser77.
Thus, the H-2Kbm3–dEV8 complex is another example of
the important accessory role of solvent in stabilizing pro-
tein-ligand interfaces, as well as playing a direct role in the
ligand receptor recognition.
Thus far, only limited data are available delineating the
role of bound water in the TCR–pMHC interface. The
BM3.3/H-2Kb–pBM1 structure was the first to reveal an
extensive network of bound waters in a TCR–pMHC in-
terface (28), although waters were originally identified in
the 2C/H-2Kb–dEV8 complex (26). The unusual confor-
mation and size of the CDR3  loop in BM3.3/H-2Kb–
Table III. Affinity Measurements of Peptides Binding to H-2Kb 
and H-2Kbm3
23 C
KD (nM)
37 C
KD (nM)
H-2Kb
OVA8 4.5 82.2
dEV8 11.1 90.1
H-2Kbm3
OVA8 13.3 160.2
dEV8 1.3 30.4
The values are the means of three independent experiments. The
standard errors of these values are between 10–15%.1184 Crystal Structure of an Alloreactive TCR–pMHC Complex
pBM1 complex creates a cavity which is filled by  30 wa-
ter molecules. The structure of 2C/H-2Kbm3–dEV8 com-
plex also highlights numerous waters in the TCR–pMHC
interface. As more TCR–pMHC structures are determined
to higher resolution, the role of waters in TCR–pMHC
binding will be elucidated, much as it was in the case of
antibody–antigen recognition. Higher resolution structures
of antibody–antigen complexes have demonstrated that bound
waters participate extensively in shaping the complemen-
tary surfaces of the antibody and antigen (62–66).
The BM3.3/H-2Kb–pBM1 structure formally estab-
lished that, in an allogeneic interaction, the TCR–pMHC
binding orientation is still diagonal (28); however, as the
structure for the corresponding TCR/self-ligand complex
has not yet been determined, the degree of similarity with
the syngeneic complex cannot be ascertained. The 2C/
H-2Kbm3–dEV8 complex confirms the observation that al-
logeneic TCR–pMHC interactions are oriented diagonally
and, furthermore, demonstrates that the structural differ-
ences between an allogeneic and syngeneic interaction can
be exceedingly subtle. In the BM3.3/H-2Kb–pBM1 and
2C/H-2Kbm3–dEV8 interactions,  -chain–pMHC contacts
are increased and become emphasized. However, with only
two allogeneic structures available, whether this correlates
with alloreactivity itself remains conjecture. Of note, the
H-2Ld–QL9 alloligand has been predicted to increase sub-
stantially the interactions with the 2C  -chain through a
COOH-terminal bulge in the peptide formed to accom-
modate a prominent ridge in the floor of the H-2Ld bind-
ing groove (67). However, it is apparent that relatively
innocuous, even buried, polymorphisms can alter the pre-
sentation of the peptide itself, and, hence, lead to alloreac-
tive TCR specificity and biological outcome.
Although the overall change in individual structures, as
measured by r.m.s. deviations, appears minimal, shape com-
plementarity coefficients and buried surface area calcula-
tions, as well as the distribution of TCR–pMHC contacts,
indicate that the summation of changes amounts to a subtle,
but global shift, in the nature of TCR binding such that
 -chain–pMHC interactions become a more dominant fea-
ture. The 2C/H-2Kbm3–dEV8 is the first structure for
which an analysis of this type has been possible, pointing to
the importance of accumulating more structural informa-
tion that addresses the question as to how TCRs distinguish
between syngeneic and allogeneic ligands. Such informa-
tion will provide invaluable insights into immunological
phenomena that directly affect human health and disease.
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